Synonyms: BMY-28142 | BMY28142 | CFPM | Maxipime® | Renapime®
cefepime is an approved drug (FDA (1996), UK (2017))
Compound class:
Synthetic organic
Comment: Cefepime is a semisynthetic, broad-spectrum, fourth-generation cephalosporin antibacterial [1-2]. It was removed from the World Health Organization's List of Essential Medicines in 2019.
|
|
References |
1. Fuchs PC, Jones RN, Barry AL, Thornsberry C. (1985)
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother, 27 (5): 679-82. [PMID:3893316] |
2. Tomatsu K, Ando S, Masuyoshi S, Hirano M, Miyaki T, Kawaguchi H. (1986)
Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin. J Antibiot, 39 (11): 1584-91. [PMID:3539901] |